IRUBIS GmbH
IRUBIS GmbH, founded in 2017, developed Monipa to speed up biological drug market entry using process analytical technology.
Introduction
IRUBIS GmbH, a Munich-based startup co-founded by Anja Müller, Alexander Geißler, and Lorenz Sykora-Mirle in 2017, has innovated with Monipa to expedite the development and market introduction of biological drugs. Monipa represents a transformative process analytical technology that enhances the efficiency and effectiveness of this critical pharmaceutical area.
Information
Categories
More Websites
A company offering customized chemical materials and solutions, focusing on R&D, supply chain, and problem-solving in special adhesives, composites, and other fields.
Lock & Key Biosciences GmbH aims to empower the fine chemical industry with innovative biocatalytic technologies for enhanced reactivity and efficiency.
H.C. Starck Ceramics makes machine parts from various materials in diverse shapes for small to medium batches.